dabrafenib mesylate (CAS No. 1195768-06-9) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of per batch COA (not published). Main applications include Pharmaceutical Intermediates &；APIs. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.
| CAS Number | 1195768-06-9 |
|---|---|
| Molecular Formula | C23H20F3N5O2S2 |
| Molecular Weight | 519.6 |
| Boiling Point | 653.7 |
| LogP | 2.9 |
| Purity | per batch COA (not published) |
| Packaging | per order / batch confirmation (not published) |
| Applications | Pharmaceutical Intermediates &；APIs |
| Category | Pharmaceutical Intermediates & APIs |
Pharmaceutical Intermediates &；APIs
COA (Certificate of Analysis) is provided with every batch. MSDS/technical data sheets and third-party test reports are available on request. Purity and packaging are subject to batch COA and order confirmation.
dabrafenib mesylate is a pharmaceutical intermediate or API compound with CAS registry number 1195768-06-9 and molecular formula C23H20F3N5O2S2 (molecular weight 519.6), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.
Pharmaceutical intermediates and APIs are critical building blocks for drug synthesis, with strict requirements on purity, impurities and process consistency.
dabrafenib mesylate is typically applied in Pharmaceutical Intermediates &, APIs.
Jinan Shenghe Chemical Co., Ltd. supplies dabrafenib mesylate with stable inventory and provides a Certificate of Analysis (COA) with each batch; custom repacking is available per process requirement.
CAS number: 1195768-06-9 — searchable in PubChem for physicochemical, safety and regulatory data.
Its molecular formula C23H20F3N5O2S2 comprises 23 C, 20 H, 3 F, 5 N, 2 O, 2 S atoms.
Also known as: dabrafenib mesylate
Category: pharmaceutical intermediates and APIs
Used in API synthesis, formulation and pre-clinical research; supplied with COA and impurity-profile documentation.
In the Pharmaceutical Intermediates & field, dabrafenib mesylate is selected for its consistent quality and documented specifications. In the APIs field, dabrafenib mesylate is selected for its consistent quality and documented specifications.
Typical purity is per batch COA (not published). Packaging is per order / batch confirmation (not published). Storage: sealed, in a cool and dry place. Each batch ships with a COA; MSDS and other technical documents are available on request.
Supplier: Jinan Shenghe Chemical Co., Ltd.. Samples can be arranged on request; lead time depends on stock and order size. Quotes are returned within one business day by email or WhatsApp.
Email: info@591daili.com · Tel/WhatsApp: +86-18553102138
The CAS number of dabrafenib mesylate is 1195768-06-9.
Typical purity is per batch COA (not published), supplied in per order / batch confirmation (not published), with COA provided.
Main applications include Pharmaceutical Intermediates &；APIs.
Each batch ships with a Certificate of Analysis (COA). MSDS and other technical documents are available on request.
Store sealed in a cool, dry place. Handling and PPE follow the MSDS supplied with the batch; general chemical-handling precautions are recommended.
Samples are available on request. Please contact us at info@591daili.com or via WhatsApp for details.
Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..
dabrafenib mesylate · CAS 1195768-06-9 · C23H20F3N5O2S2. UNII QGP4HA4G1B. Boiling Point: 653.7; LogP: 2.9; Dissociation Constants: -1.5.
| CAS Registry Number | 1195768-06-9 |
|---|---|
| PubChem CID | 44462760 |
| Molecular formula | C23H20F3N5O2S2 |
| IUPAC name | N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide |
| UNII (FDA) | QGP4HA4G1B |
| Molecular Weight | 519.6 |
|---|---|
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 6 |
| Exact Mass | 519.10105173 |
| Monoisotopic Mass | 519.10105173 |
| Topological Polar Surface Area | 147 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Boiling Point | 653.7 |
|---|---|
| LogP | 2.9 |
| Dissociation Constants | -1.5 |
| Reported hazard statements | H361 (22.2%), H373 (88.9%), H400 (100%), H410 (11.1%), H411 (88.9%) |
|---|
H361 (22.2%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H361fd (77.8%): Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity]
Dabrafenib; 1195765-45-7; GSK2118436A; GSK2118436; GSK-2118436; GSK-2118436A; QGP4HA4G1B; CHEBI:75045; DTXSID20152499; N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide; N-(3-(5-(2-AMINOPYRIMIDIN-4-YL)-2-TERT-BUTYL-1,3-THIAZOL-4-YL)-2-FLUOROPHENYL)-2,6-DIFLUOROBENZENESULFONAMIDE; N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide; dabrafenibum; RefChem:58040; DTXCID8074990; BRAF Inhibitor GSK2118436
CAS 1195768-06-9; molecular formula C23H20F3N5O2S2; molecular weight — g/mol.
Dabrafenib, 1195765-45-7, GSK2118436A, GSK2118436, GSK-2118436, GSK-2118436A.
Hazard statements reported: H361, H373, H400, H410, H411.
Boiling Point: 653.7; LogP: 2.9; Dissociation Constants: -1.5.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 甲磺酸达拉非尼